Exaggerated report of benefits in a flawed long term statin treatment study

BMJ. 2017 Oct 31:359:j4915. doi: 10.1136/bmj.j4915.

Authors

David Diamond¹, Malcolm Kendrick², Luca Mascitelli³

Affiliations

¹ Departments of Psychology, Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida 33647, USA.
² East Cheshire Trust, Macclesfield District General Hospital, Macclesfield, UK.
³ Medical Service, Comando Brigata Alpina "Julia"/Multinational Land Force, Udine, Italy.

PMID: 29089296
DOI: 10.1136/bmj.j4915

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Long-Term Care
Longitudinal Studies*
Treatment Outcome

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors